Literature DB >> 7789917

Serum levels of relaxin during the menstrual cycle and oral contraceptive use.

U Wreje1, P Kristiansson, H Aberg, B Byström, B von Schoultz.   

Abstract

Serum relaxin levels were analysed in 12 healthy women every other day during the menstrual cycle and during a second cycle on oral contraceptives. Relaxin levels in 7 women with posterior pelvic and lumbar pain were also measured. Relaxin was detected during both the follicular and luteal phases of the menstrual cycle in some of the healthy women. Serum levels were further increased during the use of oral contraceptives. Oestradiol levels in the untreated women correlated to the relaxin levels. Women with posterior pelvic and lumbar pain had higher relaxin levels than did healthy women, a finding that needs to be further explored. Our data indicate the existence of sources for relaxin production other than the corpus luteum in the non-pregnant woman. Endogenous and exogenous oestrogens may stimulate the production of relaxin.

Entities:  

Keywords:  Anatomy; Biology; Clinical Research; Contraception; Contraceptive Methods; Corpus Luteum Hormones; Developed Countries; Diseases; Endocrine System; Europe; Family Planning; Hormones; Menstrual Cycle; Menstruation; Northern Europe; Oral Contraceptives; Oral Contraceptives, Combined; Ovulation; Pain; Pelvis; Physiology; Reproduction; Research Report; Scandinavia; Signs And Symptoms; Sweden

Mesh:

Substances:

Year:  1995        PMID: 7789917     DOI: 10.1159/000292408

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  8 in total

1.  Relaxin is a potent renal vasodilator in conscious rats.

Authors:  L A Danielson; O D Sherwood; K P Conrad
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

2.  ACL Research Retreat VII: An Update on Anterior Cruciate Ligament Injury Risk Factor Identification, Screening, and Prevention.

Authors:  Sandra J Shultz; Randy J Schmitz; Anne Benjaminse; Malcolm Collins; Kevin Ford; Anthony S Kulas
Journal:  J Athl Train       Date:  2015-09-04       Impact factor: 2.860

Review 3.  The effects of the menstrual cycle on anterior knee laxity: a systematic review.

Authors:  Bohdanna T Zazulak; Mark Paterno; Gregory D Myer; William A Romani; Timothy E Hewett
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

4.  Anterior cruciate ligament laxity related to the menstrual cycle: an updated systematic review of the literature.

Authors:  Lesley Belanger; Dawn Burt; Julia Callaghan; Sheena Clifton; Brian J Gleberzon
Journal:  J Can Chiropr Assoc       Date:  2013-03

5.  Trends in serum relaxin concentration among elite collegiate female athletes.

Authors:  Jason L Dragoo; Tiffany N Castillo; Tatiana A Korotkova; Ashleigh C Kennedy; Hyeon Joo Kim; Dennis R Stewart
Journal:  Int J Womens Health       Date:  2011-01-19

6.  Sensitivity of the fasciae to sex hormone levels: Modulation of collagen-I, collagen-III and fibrillin production.

Authors:  Caterina Fede; Carmelo Pirri; Chenglei Fan; Giovanna Albertin; Andrea Porzionato; Veronica Macchi; Raffaele De Caro; Carla Stecco
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

Review 7.  Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases.

Authors:  Alana Aragón-Herrera; Sandra Feijóo-Bandín; Laura Anido-Varela; Sandra Moraña-Fernández; Esther Roselló-Lletí; Manuel Portolés; Estefanía Tarazón; Oreste Gualillo; José Ramón González-Juanatey; Francisca Lago
Journal:  J Pers Med       Date:  2022-06-21

Review 8.  The effect of relaxin on the musculoskeletal system.

Authors:  F Dehghan; B S Haerian; S Muniandy; A Yusof; J L Dragoo; N Salleh
Journal:  Scand J Med Sci Sports       Date:  2013-11-28       Impact factor: 4.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.